#None #Barcelona #Neurodegenerative #FINN Partners #AD/PD™

FINN Partners Appointed Global Agency of Record for AD/PD™ Conference

On September 14, 2026, it was announced that FINN Partners has been selected as the Global Public Relations Agency of Record for the prestigious AD/PD™ conference. As a leading international event focused on advancing science and treatment strategies for neurodegenerative diseases, AD/PD™ has been instrumental in bridging the gap between cutting-edge research and real-world care.

Elevating Global Visibility

This partnership marks a pivotal moment for the AD/PD™ conference, as FINN Partners aims to launch a comprehensive global communications campaign to increase visibility. The upcoming AD/PD™ 2027 conference is set to take place from March 16 to 20, 2027, in the beautiful city of Barcelona, Spain, functioning as a hybrid event that includes both in-person and online participation.

Dr. Abraham Fisher, Co-founder and President of AD/PD™, emphasized the conference's unique position within the scientific community: "What sets AD/PD™ apart is our comprehensive focus across the spectrum of neurodegenerative diseases. Our commitment to fostering collaboration among scientists, clinicians, and industry leaders will enable us to translate research breakthroughs into tangible patient care solutions."

The Role of FINN Partners

Leveraging its expertise in global health communications, particularly in neurology and medical technology, FINN Partners will spearhead media relations and stakeholder engagement efforts for the conference. By expanding the conference's global footprint, the agency aims to enhance participation from international clinical and scientific communities, reinforcing AD/PD™'s reputation as a vital forum for translational neuroscience.

Richard Hatzfeld, Senior Partner and Brain Health Lead at FINN Partners, highlighted the urgency of addressing brain health issues: "Brain health is one of the most critical and rapidly evolving domains in medicine today, impacting millions of families globally. We are honored to act as the strategic PR partner for AD/PD™, mobilizing our collaborative model to elevate their mission on a global scale."

Focus on Breakthrough Research

FINN Partners' role encompasses driving international abstract submissions and increasing delegate participation, ensuring that innovative research is spotlighted across the conference's twelve scientific tracks. Additionally, the agency will communicate key milestones and groundbreaking discoveries leading up to and during the event.

Ellie Hanson, Senior Partner and co-lead of FINN Partners Israel, remarked on the alignment of their work with AD/PD™: "Many of our biotech and pharma clients have historically contributed to significant research presented at AD/PD™. This partnership represents a seamless extension of our commitment to advancing knowledge in the neurodegenerative space."

About AD/PD™

The AD/PD™ International Conference on Alzheimer's and Parkinson's Diseases and Related Disorders is globally recognized as the foremost scientific forum dedicated to translational research and clinical care in neurodegenerative conditions. Founded in 1985, the past AD/PD™ 2026 conference convened roughly 6,000 researchers, clinicians, and industry innovators from more than seventy countries.

AD/PD™ aims to bridge the gap between fundamental science and clinical practice, featuring the latest advancements in disease mechanisms, the discovery of biomarkers, novel therapeutics, and innovative clinical trial designs, ultimately driving the development of life-changing treatments for neurodegenerative diseases worldwide.

For more information about the conference, visit the AD/PD™ website at adpd.kenes.com and follow the event on various social media channels including Facebook, LinkedIn, YouTube, X, and Instagram.

About FINN Partners

Founded on the principles of innovation and collaborative partnerships, FINN Partners has experienced tremendous growth from $24 million in fees to nearly $200 million in fees over the last 15 years. It ranks among the fastest-growing independent public relations agencies worldwide and has been recognized for its innovation and effectiveness in health communications.

With over 1,300 professionals spread across thirty-nine offices globally, FINN Partners continues to deliver excellence in communications, particularly in the realm of health and well-being. Their proactive approach is evident in their commitment to advancing the global conversation around health issues and scientific discovery.

Their headquarters is located in New York, and they maintain a sprawling network of offices globally, providing clients unrivaled access to top-tier agencies and markets around the world.